DE69731968D1 - Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung - Google Patents

Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung

Info

Publication number
DE69731968D1
DE69731968D1 DE69731968T DE69731968T DE69731968D1 DE 69731968 D1 DE69731968 D1 DE 69731968D1 DE 69731968 T DE69731968 T DE 69731968T DE 69731968 T DE69731968 T DE 69731968T DE 69731968 D1 DE69731968 D1 DE 69731968D1
Authority
DE
Germany
Prior art keywords
treatment
isovaleramide
spastic
epilepsy
headache
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69731968T
Other languages
English (en)
Other versions
DE69731968T2 (de
Inventor
D Artman
F Balandrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire NPS Pharmaceuticals Inc
Original Assignee
NPS Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NPS Pharmaceuticals Inc filed Critical NPS Pharmaceuticals Inc
Publication of DE69731968D1 publication Critical patent/DE69731968D1/de
Application granted granted Critical
Publication of DE69731968T2 publication Critical patent/DE69731968T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Psychology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cephalosporin Compounds (AREA)
DE69731968T 1996-08-30 1997-08-29 Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung Expired - Fee Related DE69731968T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2505096P 1996-08-30 1996-08-30
US25050P 1996-08-30
PCT/US1997/015272 WO1998008498A1 (en) 1996-08-30 1997-08-29 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants

Publications (2)

Publication Number Publication Date
DE69731968D1 true DE69731968D1 (de) 2005-01-20
DE69731968T2 DE69731968T2 (de) 2005-12-22

Family

ID=21823778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69731968T Expired - Fee Related DE69731968T2 (de) 1996-08-30 1997-08-29 Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung

Country Status (16)

Country Link
EP (1) EP0938304B1 (de)
JP (1) JP2000504035A (de)
KR (1) KR100594400B1 (de)
CN (2) CN1152677C (de)
AT (1) ATE284683T1 (de)
AU (1) AU728765B2 (de)
BR (1) BR9713188A (de)
CA (1) CA2264577A1 (de)
DE (1) DE69731968T2 (de)
DK (1) DK0938304T3 (de)
ES (1) ES2235251T3 (de)
HK (1) HK1023725A1 (de)
IL (1) IL128724A (de)
PT (1) PT938304E (de)
RU (1) RU2232016C2 (de)
WO (1) WO1998008498A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589994B1 (en) * 1996-08-30 2003-07-08 Nps Pharmaceuticals, Inc. Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound
EP1059930B1 (de) * 1998-03-04 2005-05-11 Nps Pharmaceuticals, Inc. Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen
AU2003204485B2 (en) * 1998-03-04 2006-06-08 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
EP1576962A1 (de) * 1998-03-04 2005-09-21 Nps Pharmaceuticals, Inc. Zusammensetzungen enthaltend Isovalerianamide zusammen mit ibuprofen
US6383527B1 (en) * 1999-03-04 2002-05-07 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID
US6346283B1 (en) * 1999-03-26 2002-02-12 Ancile Pharmaceuticals Use of valeriana for the treatment of restless leg syndrome and related disorders
EP1225888A2 (de) * 1999-10-19 2002-07-31 Nps Pharmaceuticals, Inc. Formulierungen mit verzögerter freisetzung zur behandlung von zns-vermittelten störungen
US7235258B1 (en) 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
SI1311256T1 (sl) * 2000-08-17 2005-12-31 Teva Pharma Uporaba derivatov amidov valprojske kisline in amidov 2-valproenske kisline za zdravljenje ali preprecevanje bolecin in/ali glavobolnih motenj
EP1385520A4 (de) * 2001-02-08 2007-03-21 Nps Pharma Inc Methoden und verbindungen zur behandlung von neurologischen und neuropsychiatrischen erkrankungen und zur identifizierung von verbindungen zur behandlung derselben
WO2003063605A1 (en) * 2002-02-01 2003-08-07 Eugene Science Inc. Chewing gum composition containing plant sterol for decrease of flood cholesterol levels and prevention of periodontal disease
WO2006012603A2 (en) * 2004-07-22 2006-02-02 Nps Pharmaceuticals, Inc. Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
DE102006062264A1 (de) * 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
RU2460534C1 (ru) * 2011-04-15 2012-09-10 Учреждение Российская академия наук Сибирское отделение (СО РАН) Институт общей и экспериментальной биологии (ИОЭБ СО РАН) Способ получения средства, обладающего анксиолитической активностью
CN103565959B (zh) * 2013-11-06 2015-04-08 李传平 一种治疗精神分裂症的汤剂
CN103961341B (zh) * 2014-05-30 2015-12-02 杨献华 一种治疗偏头痛的药物组合物及其应用
CN109071424B (zh) * 2016-02-29 2022-01-14 生物药品解决方案有限公司 氨基磺酸酯衍生物化合物、其制备方法及用途
KR102333460B1 (ko) * 2016-11-15 2021-12-15 경희대학교 산학협력단 쥐오줌풀 추출물을 유효성분으로 포함하는 측두엽 뇌전증 예방 또는 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617555C3 (de) * 1966-04-19 1974-09-19 Kali-Chemie Ag, 3000 Hannover Verfahren zur Isolierung von therapeutisch wertvollen Isovaleriansäureestern aus Valeriana- und Kentranthus-Extrakten
DE2230626B2 (de) * 1972-06-22 1978-07-20 Roland Dr. 7967 Bad Waldsee Schaette Baldrianpräparat
US5506268A (en) * 1993-06-11 1996-04-09 Nps Pharmaceuticals, Inc. Use of isovaleramide as a mild anxiolytic and sedative agent

Also Published As

Publication number Publication date
IL128724A0 (en) 2000-01-31
IL128724A (en) 2003-05-29
DK0938304T3 (da) 2005-03-14
CN1152677C (zh) 2004-06-09
AU4330297A (en) 1998-03-19
KR20000038194A (ko) 2000-07-05
AU728765B2 (en) 2001-01-18
HK1023725A1 (en) 2000-09-22
CN1235541A (zh) 1999-11-17
ATE284683T1 (de) 2005-01-15
BR9713188A (pt) 1999-11-03
RU2232016C2 (ru) 2004-07-10
WO1998008498A1 (en) 1998-03-05
ES2235251T3 (es) 2005-07-01
PT938304E (pt) 2005-04-29
CN1531924A (zh) 2004-09-29
KR100594400B1 (ko) 2006-07-03
EP0938304B1 (de) 2004-12-15
CA2264577A1 (en) 1998-03-05
EP0938304A1 (de) 1999-09-01
JP2000504035A (ja) 2000-04-04
DE69731968T2 (de) 2005-12-22

Similar Documents

Publication Publication Date Title
DE69731968D1 (de) Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung
WO2000051586A3 (en) Treating a variety of pathological conditions, including spasticity and convulsions, by effecting modulation of cns activity with isovaleramide, isovaleric acid, or a related compound
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
CA2265766A1 (en) Rapidly disintegrating pellets
BG104679A (en) The use of fumaric acid derivatives in transplant medicine
BG102733A (en) New substituted cyclic amino acids as pharmaceutical forms
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
PL311654A1 (en) High-dosage preparations
EP0783299A4 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
ATE229533T1 (de) Nitrat-salze als arzneimittel
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
IL111293A0 (en) Pharmaceutical compositions comprising 5 alpha-reductase type 2 inhibitor for treating androgenic alopecia
DK1167354T3 (da) Racemisk huperzin A
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
IL109982A0 (en) Pharmaceutical compositions containing isovaleramide and methods for the preparation thereof
PT1057826E (pt) Derivados carboxamidicos dimericos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem
BG105014A (en) Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
ZA935086B (en) Skin regenerating cosmetic composition
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
AU2287197A (en) Heterocyclic compounds and their preparation and use
WO1997019669A3 (en) Heterocyclic compounds and their use
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.
UA29558C2 (uk) Препарат для лікування бронхіальної астми " еуфілін-н 200"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee